Business Context and Reporting Period
This Form 8-K Current Report was filed by Lions Gate Entertainment Corp. on July 19, 2018. The filing addresses corporate governance changes, specifically the nomination of new directors and the departure of current directors ahead of the Annual General and Special Meeting of Shareholders scheduled for September 11, 2018.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel and governance matters rather than financial performance.
Material Changes
- Board Composition: The Board has resolved to set the number of directors at 13.
- Director Departures: Dr. John C. Malone and Scott Paterson will not stand for re-election. They will continue to serve until the date of the Annual Meeting.
- Director Nominations: Susan McCaw and Daniel Sanchez have been nominated to serve as directors if elected. The full slate of 13 nominees includes Michael Burns, Gordon Crawford, Arthur Evrensel, Jon Feltheimer, Emily Fine, Michael T. Fries, Sir Lucian Grainge, Mark H. Rachesky, Daryl Simm, Hardwick Simmons, and David M. Zaslav.
Guidance, Outlook, and Management Commentary
Management disclosed this information under Regulation FD during meetings with investors and analysts. The filing notes the professional backgrounds of the new nominees:
- Susan McCaw: President of COM Investments since 2004, former U.S. Ambassador to Austria, and former Managing Partner of Eagle Creek Capital. She holds various board positions including the Malala Fund and Stanford University.
- Daniel Sanchez: A private practice lawyer focusing on tax planning since 1990. He is the nephew of Dr. Malone and previously served as a director of Starz (which merged with the Company) and Discovery Communications, Inc.
The filing does not contain financial guidance, risk factors, or contingencies related to operations.
Investor Verification Checklist
- Confirm the election results of the 13 director nominees at the September 11, 2018 Annual Meeting.
- Verify the transition timeline for Dr. Malone and Scott Paterson as they step down from the Board.
- Review the proxy statement for detailed biographical information and potential conflicts of interest for the new nominees.
- Note that this filing contains no financial data; refer to the most recent 10-K or 10-Q for financial metrics.